Clinical Trial Update: Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating neoadjuvant immune checkpoint inhibitors and novel immuno-oncology combinations for early-stage …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Colon Carcinoma | Phase 2 | Status: RECRUITING